We offer patient-centric, science driven real-world research. At Vitaccess, we redefine the landscape of real-world evidence (RWE) generation through our groundbreaking Vitaccess Real™ platform. Powering your studies, our platform and our expert team enable you to gain deeper and faster insights into the impact of diseases and treatments in the real world. We are: Specialists in Real-World Primary Data Collection: We design and run studies collecting data directly from patients, caregivers, and clinicians, ensuring full study management. Patient-Centric: We prioritize multi-stakeholder co-creation with patient groups and clinical experts, ensuring an inclusive methodology and patient-relevant data collection. Our patient-centric research can help you generate data on caregiver burden, adherence, burden of illness, preferences and utilities, symptoms, patient experience, physical function, work productivity, treatment satisfaction, social function, functional status, quality of life, healthcare-related costs, out-of-pocket costs, health status and more.
Looking for a particular Vitaccess employee's phone or email?
The Vitaccess annual revenue was $12.4 million in 2026.
Mark Larkin is the Founder and CEO of Vitaccess.
27 people are employed at Vitaccess.
The NAICS codes for Vitaccess are [5182, 51, 51821, 518210, 518].
The SIC codes for Vitaccess are [737, 73].